1. Li J, Wang W, Xia P, Wan L, Zhang L, Yu L, Wang L, Chen X*, Xiao Y*, Xu C*. Identification of a fivelncRNA signature for predicting the risk of tumor recurrence in breast cancer patients. International Journal of Cancer. 2018; 143:2150-2160.
  2. Yan A, Ban Y, Gao Z, Chen X*, Wang L*. PathwaySplice: An R package for unbiased pathway analysis of alternative splicing in RNA-Seq data. Bioinformatics. 2018;34(18): 3220-3222.
  3. Garg B, Giri B, Modi S, Sethi V, Castro I, Umland O, Ban Y, Lavania S, Dawra R, Banerjee S, Vickers S, Merchant NB, Chen SX, Gilboa E, Ramakrishnan S, Saluja A, Dudeja V. NFκB in Pancreatic Stellate Cells Reduces Infiltration of Tumors by Cytotoxic T Cells and Killing of Cancer Cells, via Upregulation of CXCL12. Gastroenterology. 2018; 155(3):880-891.
  4. Nagathihalli NS, Castellanos JA, Lamichhane P, Messaggio F, Shi C, Dai X, Rai P, Chen X, VanSaun MN, Merchant NB. . Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreatic Cancer. Cancer research. 2018; 78(21): 6235-46.
  5. DeBose-Scarlett A, Balise R, Kwon D, Vadaparampil S, Chen SX, Schiff ER, Ayala GP, Thomas E. Obstacles to successful treatment of hepatitis C in uninsured patients from a minority population. Journal of Translational Medicine. 2018; 16(1):178.
  6. Uppada SB, Gowrikumar S, Ahmad R, Kumar B, Szeglin B, Chen X, Smith JJ, Batra SK, Singh Ab, Dhawan P. MASTL induces Colon Cancer progression and Chemoresistance by promoting Wnt/β-catenin signaling. Molecular Cancer. 2018; 17(1):111.
  7. Ward NC, Yu A, Moro A, Ban Y, Chen X, Hsiung S, Keegan J, Arbanas JM, Loubeau M, Thankappan A, Yamniuk AP, Davis JH, Struthers M, Malek TR. IL-2/CD25: A Long-Acting Fusion Protein That Promotes Immune Tolerance by Selectively Targeting the IL-2 Receptor on Regulatory T Cells. The Journal of Immunology. 2018; 201(9): 2579-92.
  8. SJ, Yechieli R, Zhao W, Kodiyan J, Asher D, Chinea FM, Patel V, Reis IM, Wang L, Wilky BA, Subhawong T, Trent JC (2018). Limb-sparing surgery plus radiotherapy results in superior survival: an analysis of patients with high-grade, extremity soft-tissue sarcoma from the NCDB and SEER. Cancer Med 7:4228-4239 PMCID: PMC6144142
  9. BA DeRosa, JE Hokayem, E Artimovich, C Garcia-Serje, AW Phillips, DV Booven, JE Nestor, L Wang, ML Cuccaro, JM Vance, MA Pericak-Vance, HN Cukier, MW Nestor, DM Dykxhoorn (2018) Convergent Pathways in Idiopathic Autism Revealed by Time Course Transcriptomic Analysis of Patient-Derived Neurons. Sci Rep. 8(1) : 8423